2020 annual financial data

Kiniksa Pharmaceuticals International 2020 Net margin

Direct answer

Net margin was -2,094.77%.

Operating income was -157,363,000 USD and net income was -161,381,000 USD.
Operating cash flow was -136,532,000 USD.

Get free Kiniksa Pharmaceuticals International email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
7,704,000 USD
Operating income
-157,363,000 USD
Net income
-161,381,000 USD
Operating cash flow
-136,532,000 USD